However, safety varies significantly based on individual factors including age, liver and kidney function, concurrent medications, and underlying genetic polymorphisms affecting antioxidant metabolism
Initial consumer insights on GLP-1 drugs from global market intelligence company Mintel shows that two camps are quickly forming: those open to utilising the drugs to manage weight and those who have no interest in the drugs but who want the benefits that come with the drugs
Furthermore, the KDIGO 2024 guidelines cover combination therapy from the perspective of SGLT2is being first-line therapy, and long-acting GLP-1 RAs being an add-on in adults with CKD and T2D who have not achieved individualised glycaemic targets despite use of metformin and SGLT2is, or who are unable to use those medications [2]
Here's everything you need to know about glutathione IV therapy: what it is, how a session works, the real benefits, what results to expect, and answers to the questions we hear most often from clients considering this treatment
Therapeutic Applications and Future Potential Diagram illustrating NAD+ metabolism, including biosynthesis, degradation pathways, and related enzymes and functions
